Cytogenetic chromosomal preparations using 2-methoxyestradiol

被引:2
|
作者
Attalla, H
Knuutila, S
Mäkelä, TP
Andersson, LC
Adlercreutz, H
机构
[1] Univ Helsinki, Dept Clin Chem, Helsinki 00290, Finland
[2] Univ Helsinki, Dept Med Genet, Helsinki 00290, Finland
[3] Univ Helsinki, Haartman Inst, Helsinki 00290, Finland
[4] Karolinska Hosp, Dept Pathol, S-10401 Stockholm, Sweden
基金
芬兰科学院;
关键词
D O I
10.1016/S0165-4608(97)00341-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The antimitotic drug 2-methoxyestradiol is an end metabolite of catechol estrogens. In vivo, it arrests cells in mitosis by interfering with the dynamics of the mitotic spindle without disrupting tubulin formation. It has a mitotic index similar to that of Colcemid in different cell lines. Here we report that 2-methoxyestradiol can be used for making cytogenetic preparations of comparable quality to that of colcemid. In addition, 2-methoxyestradiol is devoid of the toxicity associated with Colcemid, which may make 2-methoxyestradiol useful in slowly growing samples often found in primary solid tumor cultures where a sufficient number of mitotic cells is difficult to obtain. (C) Elsevier Science Inc., 1998.
引用
收藏
页码:139 / 141
页数:3
相关论文
共 50 条
  • [1] Sensitive determination of 2-methoxyestradiol in pharmaceutical preparations and serum samples using flow injection chemiluminescence
    Yao, Hanchun
    Zhang, Min
    Zeng, Wenyuan
    Zeng, Xiaoying
    Zhang, Zhenzhong
    LUMINESCENCE, 2014, 29 (03) : 261 - 265
  • [2] 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
    Azab, Samar S.
    Salama, A.
    Abdel-Naim, Ashraf B.
    Khalifa, Amani E.
    El-Demerdash, Ebtehal
    Al-Hendy, Ayman
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (01) : 9 - 19
  • [3] 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
    Samar S. Azab
    Salama A. Salama
    Ashraf B. Abdel-Naim
    Amani E. Khalifa
    Ebtehal El-Demerdash
    Ayman Al-Hendy
    Breast Cancer Research and Treatment, 2009, 113 : 9 - 19
  • [4] An efficient, practical synthesis of 2-methoxyestradiol
    Xin, Minhang
    You, Qidong
    Xiang, Hua
    STEROIDS, 2010, 75 (01) : 53 - 56
  • [5] Immunomodulation by the estrogen metabolite 2-methoxyestradiol
    Stubelius, Alexandra
    Erlandsson, Malin C.
    Islander, Ulrika
    Carlsten, Hans
    CLINICAL IMMUNOLOGY, 2014, 153 (01) : 40 - 48
  • [6] 2-Hydroxyestradiol is a prodrug of 2-methoxyestradiol
    Zacharia, LC
    Piché, CA
    Fielding, RM
    Holland, KM
    Allison, SD
    Dubey, RK
    Jackson, EK
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03): : 1093 - 1097
  • [7] Inhibition of 2-methoxyestradiol glucuronidation by probenecid
    Qian, Yuli
    Sherbini, Ahmad
    Matin, Bahar
    Zhao, Yanli
    Castellot, John
    Greenblatt, David J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2015, 67 (11) : 1585 - 1592
  • [8] An Improved Synthetic Method of 2-Methoxyestradiol
    Zhang, Bei-Na
    Wang, Hong-Bo
    Zhang, Qian
    Chen, Ying
    Xia, Peng
    Fudan University Journal of Medical Sciences, 2003, 30 (05): : 494 - 495
  • [9] 2-methoxyestradiol, a promising anticancer agent
    Lakhani, NJ
    Sarkar, MA
    Venitz, J
    Figg, WD
    PHARMACOTHERAPY, 2003, 23 (02): : 165 - 172
  • [10] Potential vascular actions of 2-methoxyestradiol
    Dubey, Raghvendra K.
    Jackson, Edwin K.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2009, 20 (08): : 374 - 379